A landscape of synergistic drug combinations in non-small-cell lung cancer

NU Nair, P Greninger, A Friedman, A Amzallag… - bioRxiv, 2021 - biorxiv.org
Targeted therapeutics have advanced cancer treatment, but single agent activity remains
limited by de novo and acquired resistance. Combining targeted drugs is broadly seen as a …

[PDF][PDF] In vitro study of a selective PI3K inhibitor on brain metastases

E Rigg - 2020 - bora.uib.no
Melanoma incidence rates in Norway have increased 8-fold in the last decades, resulting in
the highest mortality rates in Europe. Malignant melanoma is an extremely aggressive skin …